USFDA accepts under priority review GSK application to extend indication of adjuvanted RSV vaccine Ruchika Sharma8 Feb 2024 4:30 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted under priority review an application to extend the...
GSK application for Shingrix for shingles prevention in at-risk adults aged 18 and over accepted for review in China Ruchika Sharma8 Feb 2024 1:30 PM ISTLondon: GSK plc has announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted...
GSK vaccine Arexvy accepted for regulatory review by EMA for adults aged 50-59 at increased risk for RSV Ruchika Sharma4 Feb 2024 10:00 AM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to expand the use of its...
GSK settles another Zantac lawsuit in California Ruchika Sharma1 Feb 2024 4:15 PM ISTCalifornia: GSK said on Thursday it had agreed to settle another lawsuit in California that alleged its discontinued heartburn drug Zantac...
GSK Omjjara gets European Commission marketing authorisation Ruchika Sharma29 Jan 2024 4:45 PM ISTLondon: GSK plc has announced the European Commission has granted marketing authorisation for Omjjara (momelotinib), a once-a-day, oral JAK1/JAK2...
Fate of most remaining Zantac lawsuits weighed by Delaware judge Ruchika Sharma24 Jan 2024 4:11 PM ISTGSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in...
GSK raises USD 1.24 billion from latest Haleon stake sale Ruchika Sharma17 Jan 2024 5:38 PM ISTNew Delhi: GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business...
GSK to acquire Aiolos Bio for USD 1 billion Ruchika Sharma13 Jan 2024 10:00 AM ISTLondon: GSK plc and Aiolos Bio, Inc. have announced that they have entered into an agreement under which GSK will acquire Aiolos, a...
GSK Nucala approved in China for use in severe asthma with eosinophilic phenotype Ruchika Sharma12 Jan 2024 11:35 AM ISTLondon: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), as an add-on...
GSK enters exclusive license agreement with Hansoh for HS-20093 Ruchika Sharma24 Dec 2023 10:00 AM ISTLondon: GSK plc and Hansoh Pharma, a Chinese biopharmaceutical company have announced that they have entered into an exclusive license agreement...
Jemperli plus Zejula combo significantly improved progression-free survival in primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma20 Dec 2023 2:30 PM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 2 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
Fake medical factory producing duplicate Betnovate-N busted, mastermind held Roshni Dhar19 Dec 2023 5:28 PM ISTA fake medical factory preparing duplicate ‘Betnovate-N’ was busted by the Delhi Police's Crime Branch and 2,200 filled tubes and 68,000 empty tubes...
